Armata Pharmaceuticals Statistics

Total Valuation

ARMP has a market cap or net worth of $204.54 million. The enterprise value is $367.46 million.

Market Cap	204.54M
Enterprise Value	367.46M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ARMP has 36.33 million shares outstanding. The number of shares has increased by 0.16% in one year.

Current Share Class	36.33M
Shares Outstanding	36.33M
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	0.77%
Owned by Institutions (%)	2.09%
Float	10.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	40.32
Forward PS	133.68
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	72.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.12

Current Ratio	0.12
Quick Ratio	0.11
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.22

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-22.20%
Return on Invested Capital (ROIC)	-24.32%
Return on Capital Employed (ROCE)	66.13%
Revenue Per Employee	$84,233
Profits Per Employee	-$781,683
Employee Count	60
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +161.86% in the last 52 weeks. The beta is 1.25, so ARMP's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	+161.86%
50-Day Moving Average	5.14
200-Day Moving Average	2.83
Relative Strength Index (RSI)	45.54
Average Volume (20 Days)	92,552

Short Selling Information

The latest short interest is 157,247, so 0.43% of the outstanding shares have been sold short.

Short Interest	157,247
Short Previous Month	21,970
Short % of Shares Out	0.43%
Short % of Float	1.43%
Short Ratio (days to cover)	0.23

Income Statement

In the last 12 months, ARMP had revenue of $5.05 million and -$46.90 million in losses. Loss per share was -$2.22.

Revenue	5.05M
Gross Profit	-21.04M
Operating Income	-33.35M
Pretax Income	-46.90M
Net Income	-46.90M
EBITDA	-31.86M
EBIT	-33.35M
Loss Per Share	-$2.22

Full Income Statement

Balance Sheet

The company has $14.76 million in cash and $177.68 million in debt, giving a net cash position of -$162.93 million or -$4.48 per share.

Cash & Cash Equivalents	14.76M
Total Debt	177.68M
Net Cash	-162.93M
Net Cash Per Share	-$4.48
Equity (Book Value)	-95.59M
Book Value Per Share	-2.64
Working Capital	-123.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.02 million and capital expenditures -$413,000, giving a free cash flow of -$27.43 million.

Operating Cash Flow	-27.02M
Capital Expenditures	-413,000
Free Cash Flow	-27.43M
FCF Per Share	-$0.76

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-659.87%
Pretax Margin	-928.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.16%
Shareholder Yield	n/a
Earnings Yield	-22.93%
FCF Yield	-13.41%

Analyst Forecast

The average price target for ARMP is $9.00, which is 59.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	59.86%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ARMP has an Altman Z-Score of -8.47 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.47
Piotroski F-Score	3